Td. Batiuk et al., CYCLOSPORINE INHIBITION OF CALCINEURIN ACTIVITY IN HUMAN-LEUKOCYTES IN-VIVO IS RAPIDLY REVERSIBLE, The Journal of clinical investigation, 96(3), 1995, pp. 1254-1260
Despite increasing information about the mechanism of action of cyclos
porine A (CsA), lithe is known about the way lymphocytes recover from
CsA, Recovery is central to understanding the pharmacodynamics of CsA
in vivo, We studied the recovery of calcineurin phosphatase (CN) activ
ity in CsA-treated cells, Single dose kinetics in renal transplant pat
ients showed that inhibition of CN activity in PBL increased and fell
concomitant with CsA blood levels, In vitro, control PBL treated with
CsA 100 mu g/l, washed, and resuspended in CsA-free medium showed litt
Ie recovery (0-20%) after 24 h, Erythrocytes or anti-CsA Ab added to t
he recovery medium increased recovery to 50% within 4 h, Similar recov
ery was seen in the ability of cells to produce IFN-gamma after OKT3 s
timulation, Recovery of CN activity was associated with the efflux of
[H-3]CsA, was not blocked by cycloheximide and was temperature sensiti
ve, A cell line with high expression of surface P glycoprotein (PGP),
showed rapid recovery, However, PGP blockade did not prevent recovery
in PBL, indicating a different PGP-independent mechanism. In PBL, reco
very from CsA is slow and limited in vitro, but rapid in vivo, where C
sA equilibrates among a complex set of extralymphocytic binding sites.